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Key messages: 
• It is premature to conclude that heterosexual AI is not important to overall HIV 
transmission in South Africa based solely on the results of Kalichman et al [1]. 
 
• Given the high infectivity associated with receptive anal intercourse (AI), heterosexual AI 
can significantly increase the individual risk of HIV infection  
 
• Additional studies quantifying the prevalence and frequency of episodes of unprotected 
AI among heterosexuals and the contribution of AI to the HIV epidemic overall, especially 
in sub Saharan Africa are important. 
 
• Quantifying AI in clinical trials is also important because it has significant implications for 
the evaluation of interventions (such as microbicides) designed to control HIV spread 
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In this issue, Kalichman et al(1) report the results of a cross-sectional study on anal 
intercourse(AI) of heterosexual men and women in South Africa(SA)(1). This study is a welcome 
addition to the literature since there are relatively few studies quantifying rates of AI among 
heterosexual populations, especially in SA. Overall, 14% men and 10% women reported AI in the 
previous three months. Among those, 56% did in at least 50% of all sex acts and reported using 
condoms as often for AI as for vaginal intercourse(VI). Despite this, the authors concluded that 
the rate of AI was relatively low among heterosexuals and that, “even among those who do 
engage in AI, most do so at significantly lower rates than VI,” (total VI=9.90, total AI=8.47) based 
on reported mean frequencies of all (protected and unprotected) VI and AI (Table 3). However, 
we believe that the observed differences in unprotected VI and AI are not sufficient to assert this 
with confidence, especially for men (mean frequency of unprotected AI and VI acts: 3.61 and 4.56 
respectively for females, 3.11 and 3.04 for males). They further argued that, although the role of 
AI remains unclear, the HIV epidemic in SA cannot be primarily attributed to AI and that AI 
“should neither be the focus of nor ignored by HIV prevention interventions in SA”. They also 
suggest that, relative to VI, AI is unlikely to account for a large fraction of new HIV infections in 
Africa, but its role should not be underestimated given its higher transmission efficiency.  
 
As stated by the authors, an important limitation of these results is that the AI rate may be under-
estimated, given the sensitivity of subject matter and the interviewing method used (self-
administered questionnaire with minimal assistance). Studies have shown that collection methods 
for sensitive data can lead to substantial under-reporting which varies across methods, settings 
and populations(2), making comparisons difficult. For example, in a study among married men 
from the general population in Cotonou-Benin, 3.5% reported ever having AI with a woman in 
face-to-face interviews compared to 17.5% when using pooling booth surveys(3). Given the 
difficulty in evaluating the magnitude of the under-reporting, we must be cautious in concluding 
that AI is practiced at relatively low rates and then drawing further conclusions on its relative 
importance for HIV transmission within a population.  
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The reported AI rates were similar to those reported by younger populations in the US(4-5), but 
were higher than reported by other African(6-7) or European(8) studies. However, the paucity of 
data, differences between populations and methods, and the lack of information on frequency of 
sex acts makes comparison across studies difficult(9-11). Additional information related to AI 
practices that may play an important role in HIV transmission include lifetime AI, who is having 
unprotected AI with whom (e.g. casual or stable partner), at what age, when (at the start or later 
in a relationship) and the motivation for doing so.    
 
Nevertheless, even in the face of uncertainties in the estimates, an important question is: Does 
10-15% of the population engaging in AI constitute too small a fraction to influence the course of 
HIV epidemics, despite the high risk associated with AI? 
 
A recent meta-analysis suggested per-act HIV transmission probabilities of 1.7%(95%CI 0.3-8.9) 
for receptive AI and 0.08%(95%CI 0.06-0.11) for male-to-female VI from studies in developed 
countries, which roughly translates to a 20-fold increase in HIV risk per receptive AI act compared 
to receptive VI(12). However, detailed data on the transmission probability of insertive AI are 
lacking(13). Assuming that women engaging in AI have 8.2 unprotected sex acts over 3 months 
(with a HIV positive partner), 43% of which are receptive AI (as reported by the current study(1)), 
then increases in per-act HIV transmission probability of AI compared to VI of 5-, 10- and 20-fold 
translate into 3-, 5- and 9-fold increases respectively in the three-month cumulative risk of HIV 
acquisition, compared to the situation where all acts are VI (cumulative risk=0.0065)(Figure A). 
 
To further appreciate the potential role of AI, it also helps to think about other risk factors for HIV 
transmission. Increased risk due to AI is as large as the best estimates of the relative increase in 
infectivity during the acute phase of HIV, which has been estimated to range between 9.2-fold 
(95%CI 4·5–18·8)(12) and 26-fold (95%CI 12-47)(14); the acute phase is much  shorter than the 
period of time during which AI may be practiced.  Given that 22% of the participants in the current 
study reporting AI tested HIV positive (compared to 9% amongst those who did not), the potential 
 6 
for transmission may not be negligible, especially if the rate of partnership turnover is fast. In the 
current study(1), those engaging in AI reported 2.3 partners in the past 3 months compared to 1.4 
for those who did not.  
 
AI (and VI) may be more risky in SA than other developed countries due to the presence of other 
risk factors that increase HIV susceptibility and infectivity. For VI, a meta-analysis reported higher 
HIV transmission probability for developing (0.3%) than developed countries (0.08%)(12). 
However, it was not possible to know if the difference was due to under-reporting of unprotected 
sex acts, AI, or extramarital partners or due to higher prevalence of key cofactors for HIV 
transmission. In all cases, AI may have a greater role than first appears due to under-reporting 
and/or because of interacting risk factors.  
 
Figure B highlights another reason why the role of AI should not be underestimated as it may also 
jeopardise development of new vaginal microbicides by reducing their estimated effectiveness in 
clinical trials and also reducing their effectiveness in the field upon roll-out. Even 5% AI practice 
can have a marked effect on the cumulative HIV risk. The effectiveness of a microbicide with 80% 
efficacy per VI act reduces from  79% and 78% effectiveness for 1 and 3 year trials respectively, 
if there is no AI practised, to 60% and 58% if used vaginally but not anally with 5% of AI(13). This 
may lead to a drastic reduction in the statistical power in microbicide trials(15). 
 
Given these considerations, it seems premature to conclude that AI is not or was not important in 
HIV transmission. Acknowledging that AI may be important does not mean that VI is not important 
but it gives us the mandate to improve understanding of AI’s role. The next two steps should be to 
use transmission dynamic modeling to understand under which conditions AI can have a 
significant impact and to collect data to validate the resulting hypotheses. This latter calls for 
more studies similar to Kalichman et al(1), with a strong emphasis on using validated methods 
which reduce social desirability and recall biases. 
 
 7 
Word count: 1109 
 8 
References 
1. Kalichman SC, Simbayi L, Cain D, Jooste S. Heterosexual anal intercourse among community 
and clinical settings in Cape Town, South Africa. STI, in press 2009. 
 
2. Phillips A, Gomez G, Boily MC, Garnett GP. A systematic review and meta-analysis of 
interviewing tools to investigate HIV risk behaviour in developing countries. Abstract ISSTDR 
June 2009, London. 
 
3. Minani I, Alary M, Lowndes CM, et al  Higher levels of HIV-related risky behaviour reported in 
Polling Booth Surveys (PBS) compared to Face-to-Face Interviews in a General Population 
Survey (GPS) in Cotonou-BENIN (West Africa) Abstract OS1.8.03 ISSTDR June 2009, London. 
 
4. Tian LH, Peterman TA, Tao G, Brooks LC, Metcalf C, Malotte CK, Paul SM, 
Douglas JM Jr; RESPECT-2 Study Group. Heterosexual anal sex activity in the 
year after an STD clinic visit. Sex Transm Dis. 2008 Nov;35(11):905-9. 
 
5. Houston AM, Fang J, Husman C, Peralta L. More than just vaginal intercourse: anal 
intercourse and condom use patterns in the context of "main" and "casual" sexual relationships 
among urban minority adolescent females. J Pediatr Adolesc Gynecol. 2007 Oct;20(5):299-304. 
 
6. Lane T, Pettifor A, Pascoe S, Fiamma A, Rees H. Heterosexual anal intercourse increases risk 
of HIV infection among young South African men. AIDS, 2006; 2;20(1):123-125. 
 
7. Skoler-Karpoff S, Ramjee G, Ahmed K et al. Efficacy of Carraguard for prevention of HIV 
infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 
2008 372:1977-87. 
 
8. Nicolosi A, Correa Leite ML, Musicco M, Arici C, Gavazzeni G, Lazzarin A. The efficiency of 
male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a 
study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. 
Epidemiology1994 Nov;5(6):570-5. 
 
9. Karim SS, Ramjee G. Anal sex and HIV transmission in women. Am J Public Health. 1998 
Aug;88(8):1265-6.10. Sallah ED, Grunitzky-Bekele M, Bassabi K, Dodzro K, Sadzo A, Balogou 
AK, et al. Sexual behavior, knowledge and attitudes to AIDS and sexually transmitted diseases of 
students at the University of Benin (Togo). Sante (Montrouge, France). 1999 Mar-Apr;9(2):101-9. 
 
 9 
11. Van Damme L, Ramjee G and Alary M et al., Effectiveness of COL-1492, a nonoxynol-9 
vaginal gel, on HIV-1 transmission in female sex workers: a randomized controlled trial, Lancet 
360 (2002), pp. 971–977. 
 
12. Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, et al. Heterosexual risk of 
HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. 
Lancet Infect Dis2009 Feb;9(2):118-29. 
 
13. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic 
review, meta-analysis and implications for HIV prevention, submitted. 
 
14. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect 
Dis2008 Sep 1;198(5):687-93. 
 
15. McGowan I. Microbicide Trials Network. Alliance for Microbicide Development Annual 
Meeting, Key Bridge Marriot, Arlington, VA, USA, 24 April 2008 (slide #18 available at: 
http://microbicide.org/galleries/amd/McGowan.MTNTrialLearning.AMDMeeting11.FINAL.24Apr08.
pdf accessed 20 May 2009). 
  
  
 
 10
 Figure legends 
 
A) Cumulative risk of HIV acquisition for females over three months (assuming 100% of sex acts 
with a HIV positive partner) as a function of the relative increase in per-act HIV transmission 
probability per receptive anal intercourse (AI) compared to receptive vaginal intercourse (VI). The 
figure shows that AI, practiced at a rate similar to what was reported in this study(1), can rapidly 
increase the cumulative risk of HIV infection within a relationship with a HIV positive partner.  The 
cumulative risk is derived by ))1()1((1 ** fanactvafvnactv pRRpCumRisk ⋅−⋅−−=  where pv= per-
act male-to-female vaginal transmission probability; nact = total number of unprotected sex acts in 
three months; fv and fa (fv=1-fa) are the fractions of sex acts which are vaginal and anal 
respectively and RRa is the increase in risk per-act for AI compared to VI. RRa = pa/pv where pa= 
per-act receptive AI transmission probability. We assumed nact=8.17 unprotected sex acts over 
three months of which 43% are AI (fv=56%, fa=43%) (as reported by Kalichman et al for women 
reporting AI (1)); the assumed male-to-female per-act HIV transmission probability for VI is set to 
the developed country estimate of pv=0.08%(12).  
 
B) Relationship between cumulative risk of HIV acquisition for females in the intervention arm 
during a hypothetical microbicide trial of different durations (x-scale) where 0%, 1%, 5%, 10% and 
20% of sex acts are receptive anal intercourse (AI), when the microbicide has 80% efficacy when 
used vaginally and adherence is 100% for vaginal intercourse but 0% for AI. We assumed that 
2.0 acts/week are not protected by condoms and that 25% of all acts are with HIV-infected 
partners. Male-to-female VI transmission probability is assumed to be 0.3%, as for developing 
countries and 1.7% for AI(12). The dark solid line represents the risk in absence of AI (0%) which 
when compared to the trial arm without microbicide (not shown) produces an effectiveness of 
79% and 78% in a trial of 1 and 3 years respectively. The cumulative risk is calculated using a 
similar method to that used for Figure A, allowing for reduced per-act transmission probability 
according to efficacy of microbicide (further details in (13)). 
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